Case Summary:

With an M.Sc. in molecular biology and biochemistry and a Ph.D. in biomedical sciences, our client has achieved a consistent and notable record of success and influence in this area of study. When he hired North America Immigration Law Group, he undoubtedly possessed the ability to continue further in the field of immunology. After thoroughly evaluating his credentials, we agreed to file his EB-1A (Alien of Extraordinary Ability) petition. We highlighted the following information in his EB1A petition packet to lead him to EB1A success:

• We detailed the 314 times his work was cited by other researchers in at least 30 countries, confirming that these publications are well-acknowledged all around the world. Therefore, this confirms that he has a demonstrable and important influence over his peers, as they are actively using the knowledge that he is producing to advance their research works. As such, this high citation count provides concrete evidence of the scientific value of his work.
• Also, we specified his prolific publication record i.e., 26 peer-reviewed scientific articles, all of which were published in some of the most impacting journals, providing additional evidence of both his scientific proficiency and his valuable contributions to the immunology field. In addition, we noted the impressive 30 times our client appraised the work of his peers for four highly discerning journals with very stringent publishing guidelines. His peer-review contributions are confirmed by expert statements, proving his active and actual participation as a judge of the work of other experts in the field.
• It was inevitable for us to discuss his proposed research work focusing on using a novel bioinformatics method to assess viral transmission between two individuals with whole-genome and pol next-generation sequencing data, addressing some of our nation’s most pressing issues, including techniques to identify groups of people with infections to more quickly respond to these infections and therefore prevent their spread either through vaccine development or new antiretroviral regimens.
• Moreover, his research got supported by funding from leading agencies, including the National Institute of Allergy and Infectious Diseases and the National Institutes of Health. Within the NIH, the NIAID concentrates on research specific to prevent infectious, immunologic, and allergic diseases, and thus this funding grants demonstrate the ultimate importance of our client’s research.
• Besides, we incorporated four recommendation letters provided by other well-recognized researchers in the field, one of whom stated that:

“[Client’s] many contributions to immunology have solidified his status as a researcher of irreplaceable value. His continued work in the field is vital to global efforts in addressing threats such as viral infection and developing effective solutions that enhance public health.”

Successfully, we were able to persuade USCIS that our client deserves to continue his work in the United States due to its intrinsic benefits to patients and the United States’ healthcare system. Thus, our client obtained his EB1A petition approval. We would like to thank our team’s hard work and our client’s cooperation throughout the adjudication process. We also congratulate him for achieving this great milestone.